Literature DB >> 1869364

Poor efficacy of albendazole for the treatment of human taeniasis.

W C Chung1, P C Fan, C Y Lin, C C Wu.   

Abstract

In order to evaluate the efficacy of albendazole for the treatment of taeniasis, regimens of 400 mg x 1 day, 800 mg x 2 days, 800 mg x 3 days, 1200 mg x 2 days, and 1200 mg x 3 days were compared. Of 66 cases treated and investigated 7-14 days after treatment, 52 were still expelling proglottids. Three months posttreatment, these cases were re-treated with atabrine at 1.2 g per case for males and 1.0 g per case for females. Fifty-seven patients expelled worms or parts of tapeworms. The nine negatives may represent the number cured by the treatment with albendazole. The cure rates with albendazole for various regimens were up to 50% for 800 mg x 3 days, 1200 mg x 2 days or 1200 mg x 3 days, 14.3% for 800 mg x 2 days, and 0% for 400 mg x 1 day or 800 mg x 1 day. This study shows that albendazole is not very effective in the treatment for taeniasis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869364     DOI: 10.1016/0020-7519(91)90021-x

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  3 in total

1.  Study and ranking of determinants of Taenia solium infections by classification tree models.

Authors:  Kabemba E Mwape; Isaac K Phiri; Nicolas Praet; Pierre Dorny; John B Muma; Gideon Zulu; Niko Speybroeck; Sarah Gabriël
Journal:  Am J Trop Med Hyg       Date:  2014-11-17       Impact factor: 2.345

2.  A qualitative assessment of the context and enabling environment for the control of Taenia solium infections in endemic settings.

Authors:  Nicholas Ngwili; Nancy Johnson; Raphael Wahome; Samuel Githigia; Kristina Roesel; Lian Thomas
Journal:  PLoS Negl Trop Dis       Date:  2021-06-11

Review 3.  Historical overview of Taenia asiatica in Taiwan.

Authors:  Hong Kean Ooi; Chau-Mei Ho; Wen-Cheng Chung
Journal:  Korean J Parasitol       Date:  2013-02-18       Impact factor: 1.341

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.